Key facts
- This page summarizes Michael D. Popielec's Form 4 filing for ULTRALIFE CORP (ULBI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Dec 2021, 07:54.
Michael D. Popielec - 17 Dec 2021 Form 4 Insider Report for ULTRALIFE CORP (ULBI)
- Reporting relationship
- Director, President and CEO, Director
- Issuer ticker
- ULBI
- Reported as of
- 17 Dec 2021
- Net transaction value
- +$24,934
- SEC form
- 4
- Accepted by SEC
- 21 Dec 2021, 07:54:38 UTC
- Prior SEC filing
- 22 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Philip A. Fain- attorney in fact for Michael D. Popielec
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael D. Popielec filed Form 4 for ULTRALIFE CORP (ULBI) on 21 Dec 2021.
Change
- Previous filing in this sequence was filed on 22 Oct 2021.
- Current net transaction value: +$24,934.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ULBI
transaction
Common Stock; $.10 par value
Options Exercise
- Transaction value
- $24,934
- Shares
- +6,583
- Change %
- +2.1%
- Price
- $3.79
- Shares after
- 316,509
- Date
- 17 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ULBI
transaction
Derivative
Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 17 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $3.79
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares of common stock acquired by the Reporting Person upon exercise of options for 20,000 shares of common stock of the Company, net of 13,417 shares of common stock retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long-Term Incentive Plan in payment of the exercise price for the options.
Footnote F2
Represents exercise of options for 20,000 shares of common stock of the Company otherwise expiring on 3/5/2022.